A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.

Abstract

Osteoclastic bone resorption requires cell-matrix contact, an event mediated by the alpha v beta 3 integrin. The structural components of the integrin that mediate osteoclast function are, however, not in hand. To address this issue, we generated mice lacking the beta 3 integrin gene, which have dysfunctional osteoclasts. Here, we show the full rescue of beta 3(-/-) osteoclast function following expression of a full-length beta 3 integrin. In contrast, truncated beta 3, lacking a cytoplasmic domain (h beta 3c), is completely ineffective in restoring function to beta 3(-/-) osteoclasts. To identify the components of the beta 3 cytoplasmic domain regulating osteoclast function, we generated six point mutants known, in other circumstances, to mediate beta integrin signaling. Of the six, only the S(752)P substitution, which also characterizes a form of the human bleeding disorder Glanzmann's thrombasthenia, fails to rescue beta 3(-/-) osteoclasts or restore ligand-activated signaling in the form of c-src activation. Interestingly, the double mutation Y(747)F/Y(759)F, which disrupts platelet function, does not affect the osteoclast. Thus similarities and distinctions exist in the mechanisms by which the beta 3 integrin regulates platelets and osteoclasts.

0100200'03'05'07'09'11'13'15'17
Citations per Year

702 Citations

Semantic Scholar estimates that this publication has 702 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Feng2001AGM, title={A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.}, author={X L Feng and Deborah V Novack and Roberta Faccio and Daniel S . Ory and Kunihiko Aya and Martin Boyer and Kevin P. Mchugh and Frederick P. Ross and Steven L Teitelbaum}, journal={The Journal of clinical investigation}, year={2001}, volume={107 9}, pages={1137-44} }